Zobrazeno 1 - 10
of 19
pro vyhledávání: '"Wassim, Mchayleh"'
Autor:
Guru P. Sonpavde, Carlos A. Alemany, Wassim Mchayleh, Julie W. Pepe, Susan Coakley, Ashley Young, Rohit K. Jain
Publikováno v:
Journal of Clinical Oncology. 41:TPS590-TPS590
TPS590 Background: Maintenance avelumab following stable/responding disease after 4-6 cycles of platinum-based chemotherapy is a conventional first-line therapy for metastatic urothelial carcinoma (mUC). Given the attrition of patients between lines
Autor:
Hady Ghanem, Rita Assi, Wassim Mchayleh, Rita Nader, Hussein Farhat, Wissam H. Faour, Anwar Shayya, Noha Bejjani
Publikováno v:
Clinical Lymphoma Myeloma and Leukemia. 19:S306
Publikováno v:
Journal of Clinical Medicine, Vol 8, Iss 2, p 207 (2019)
Journal of Clinical Medicine
Journal of Clinical Medicine
The immune system acting via cancer immune-surveillance is considered a potential target for improving outcomes among some malignancies. The ability to harness immune cells, engineer them and educate them to target cancer cells has changed the paradi
Autor:
Wassim McHayleh, Rajesh Sehgal, Robert L. Redner, Anastasios Raptis, Mounzer Agha, James Natale, The Minh Luong, James J. Schlesselman, Kennteh A. Foon, Michael Boyiadzis
Publikováno v:
Leukemia & Lymphoma. 50:1848-1853
The most effective regimen for patients with acute myeloid leukemia (AML) who do not achieve complete remission (CR) after one course of cytarabine and an anthracycline has not been extensively studied. We evaluated restrospectively the efficacy, tox
Autor:
Mohsin Rahman, David M. Friedland, Molly Braffet, Rajesh Sehgal, Sheikh Asim Ali, Asif Ahmad, Ghassan K. Bejjani, Wassim McHayleh
Publikováno v:
Journal of Neurosurgery. 109:268-272
ObjectEndothelial proliferation has been recognized as a marker of high-grade or aggressive glioma. Bevacizumab is a humanized immunoglobulin G1 monoclonal antibody to vascular endothelial growth factor that has been shown to have activity in maligna
Autor:
John P. Morcos, Samuel A. Yousem, Ron Shapiro, Wassim McHayleh, Leonard Joseph Appleman, David M. Friedland, Tong Wu
Publikováno v:
Clinical Genitourinary Cancer. 6:53-55
We report 2 cases of renal cell carcinoma (RCC) in which the tumor arose from a transplanted allograft. The first case is a 52-year-old man with a failed cadaveric renal transplantation found to have metastatic RCC. The tumor was proven to be from th
Autor:
Wassim McHayleh, Kenneth Foon, Robert Redner, Rajesh Sehgal, Anastasios Raptis, Mounzer Agha, The Minh Luong, James J. Schlesselman, Michael Boyiadzis
Publikováno v:
Cancer. 116(12)
BACKGROUND: Elderly patients with acute myeloid leukemia (AML) are generally unable to withstand the rigors of intensive induction chemotherapy and its attendant complications. Gemtuzumab ozogamicin (GO) is an immunoconjugate that had demonstrated ac
Publikováno v:
Primer on the Metabolic Bone Diseases and Disorders of Mineral Metabolism
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::00c68fddcabe7991b71046ad5d4ad5c2
https://doi.org/10.1002/9780470623992.ch80
https://doi.org/10.1002/9780470623992.ch80
Publikováno v:
Journal of clinical oncology : official journal of the American Society of Clinical Oncology. 28(8)
Publikováno v:
American journal of hematology. 82(10)
Dendritic cell neoplasms are rare tumors that are being recognized with increasing frequency. They were previously classified as lymphomas, sarcomas, or histiocytic neoplasms. The World Health Organization (WHO) classifies dendritic cell neoplasms in